Progyny(US:PGNY)2022-08-05 10:59Financial Condition - As of June 30, 2022, the company had cash and cash equivalents of $54.7 million and marketable securities of $67.7 million[170] - A hypothetical 10% change in interest rates would not result in a material impact on the company's consolidated financial statements[171] - The company does not believe that inflation has had a material effect on its business, but significant inflationary pressures could adversely affect results of operations and financial condition[172] - A significant change in the level or mix of utilization of the company's solutions could adversely affect its financial condition and results of operations[17] - The loss of major clients or changes in pricing terms could negatively impact the company's financial condition and results of operations[17] Business Operations - The ongoing COVID-19 pandemic continues to have an adverse impact on the company's business and operations[17] - The company has a history of operating losses and may not sustain profitability in the future[17] - The company depends on its ability to retain existing clients and increase service adoption; failure to do so would harm its business[17] - The company's growth depends on the success of strategic relationships with third parties, including channel partners and vendors[17] Regulatory Environment - The company operates in a highly regulated industry and must comply with complex and evolving legal and regulatory requirements[23]